Literature DB >> 15191806

Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes.

Candice E Junge1, C Justin Lee, Katherine B Hubbard, Zhoabin Zhang, Jeffrey J Olson, John R Hepler, Daniel J Brat, Stephen F Traynelis.   

Abstract

Protease-activated receptor-1 (PAR1) is a G-protein coupled receptor that is proteolytically activated by blood-derived serine proteases. Although PAR1 is best known for its role in coagulation and hemostasis, recent findings demonstrate that PAR1 activation has actions in the central nervous system (CNS) apart from its role in the vasculature. Rodent studies have demonstrated that PAR1 is expressed throughout the brain on neurons and astrocytes. PAR1 activation in vitro and in vivo appears to influence neurodegeneration and neuroprotection in animal models of stroke and brain injury. Because of increasing evidence that PAR1 has important and diverse roles in the CNS, we explored the protein localization and function of PAR1 in human brain. PAR1 is most intensely expressed in astrocytes of white and gray matter and moderately expressed in neurons. PAR1 and GFAP co-localization demonstrates that PAR1 is expressed on the cell body and on astrocytic endfeet that invest capillaries. PAR1 activation in the U178MG human glioblastoma cell line increased PI hydrolysis and intracellular Ca(2+), indicating that PAR1 is functional in human glial-derived tumor cells. Primary cultures of human astrocytes and human glioblastoma cells respond to PAR1 activation by increasing intracellular Ca(2+). Together, these results demonstrate that PAR1 is expressed in human brain and functional in glial tumors and cultures derived from it. Because serine proteases may enter brain tissue and activate PAR1 when the blood brain barrier (BBB) breaks down, pharmacological manipulation of PAR1 signaling may provide a potential therapeutic target for neuroprotection in human neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15191806     DOI: 10.1016/j.expneurol.2004.02.018

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  85 in total

1.  Thrombin and the Protease-Activated Receptor-1 in Organophosphate-Induced Status Epilepticus.

Authors:  Valery Golderman; Efrat Shavit-Stein; Orna Gera; Joab Chapman; Arik Eisenkraft; Nicola Maggio
Journal:  J Mol Neurosci       Date:  2018-12-04       Impact factor: 3.444

2.  Kallikrein 6 is a novel molecular trigger of reactive astrogliosis.

Authors:  Isobel A Scarisbrick; Maja Radulovic; Joshua E Burda; Nadya Larson; Sachiko I Blaber; Caterina Giannini; Michael Blaber; Alexander G Vandell
Journal:  Biol Chem       Date:  2012-04       Impact factor: 3.915

3.  Integrating genetic and gene expression evidence into genome-wide association analysis of gene sets.

Authors:  Qing Xiong; Nicola Ancona; Elizabeth R Hauser; Sayan Mukherjee; Terrence S Furey
Journal:  Genome Res       Date:  2011-09-22       Impact factor: 9.043

4.  Protease-activated receptor 1 (PAR1) coupling to G(q/11) but not to G(i/o) or G(12/13) is mediated by discrete amino acids within the receptor second intracellular loop.

Authors:  Kelly L McCoy; Stefka Gyoneva; Christopher P Vellano; Alan V Smrcka; Stephen F Traynelis; John R Hepler
Journal:  Cell Signal       Date:  2012-01-28       Impact factor: 4.315

Review 5.  Protease-activated receptors: regulation of neuronal function.

Authors:  Toshiyuki Saito; Nigel W Bunnett
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

6.  Astrocytic control of synaptic NMDA receptors.

Authors:  C Justin Lee; Guido Mannaioni; Hongjie Yuan; Dong Ho Woo; Melissa B Gingrich; Stephen F Traynelis
Journal:  J Physiol       Date:  2007-04-05       Impact factor: 5.182

Review 7.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

8.  Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.

Authors:  Joshua E Burda; Maja Radulovic; Hyesook Yoon; Isobel A Scarisbrick
Journal:  Glia       Date:  2013-07-08       Impact factor: 7.452

Review 9.  What is the role of astrocyte calcium in neurophysiology?

Authors:  Cendra Agulhon; Jeremy Petravicz; Allison B McMullen; Elizabeth J Sweger; Suzanne K Minton; Sarah R Taves; Kristen B Casper; Todd A Fiacco; Ken D McCarthy
Journal:  Neuron       Date:  2008-09-25       Impact factor: 17.173

10.  PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo.

Authors:  R Auvergne; C Wu; A Connell; S Au; A Cornwell; M Osipovitch; A Benraiss; S Dangelmajer; H Guerrero-Cazares; A Quinones-Hinojosa; S A Goldman
Journal:  Oncogene       Date:  2015-11-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.